Bioworld Financial Watch articles from March 2003

Bioworld Financial Watch archives from March 2003

Deal-making rules changing; pharma, biotechs shop around.
March 3, 2003... NEW YORK -- Science is all about experiments, so here's an idea for the blackboard: Imagine a world where biotechnology pays pharmaceutical companies to develop compounds. That farfetched notion, among others, was floated during a...

Money Raised By Biotech In 2003 Vs. 2002.
March 3, 2003... Money Raised By Biotech In 2003 Vs. 2002 Jan. 1 -- Feb. 27, 2003: Jan. 1 -- Feb. 28, 2002: $1,018.00M $4,180.83M Public/Other * 253 3,177...

10 Biggest U.S. Gainers & Losers for the Week.
March 3, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Paradigm Genetics 56.52 Sheffield 50.00 CytRx 46.43 NaPro Biother 40.63 Genetronics 34.62 Immtech 33.85 NeoRx Corp. 25.64...

Biotech Mergers And Acquisitions: Oct. 17, 2002--Feb. 26, 2003 #.
March 3, 2003... Biotech Mergers And Acquisitions: Oct. 17, 2002 -- Feb. 26, 2003 # I. COMPLETED MERGERS AND ACQUISITIONS Company Acquired By Date Acquired * Or Merged With * Announced...

BioWorld Stock Report For Public Biotechnology Companies.
March 3, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change 2/21 2/28 WK YTD 3D Pharma DDDP 5.69 5.71...

London Stock Exchange.
March 3, 2003... LODON STOCK EXCHANGE Company Symbol 2/21 2/28 %WK %YTD Volume Acambis ACM 212 210 -0.94 -24.19 1931 Antisoma ASM 25.75 24.75 -3.88 -13.91 1042 British Biotech ...

Totonto Stock Exchange.
March 3, 2003... TORONTO STOCK EXCHANGE Company Symbol 2/21 2/28 %WK %YTD Volume Adherex AHX 0.41 0.36 -12.20 -16.28 67 Angiotech Pharma ANP 55.56 58.45 5.20 9.11 241 Anormed ...

AIDS controversy alive as before; this time, Phase III data and race.
March 10, 2003... Talk about a hard call. Investors may have been quick to attach their unmistakable meaning to last month's disclosure by VaxGen Inc. of disappointing Phase Ill results for its HIV vaccine u the company's stock value nosedived by 47.3...

Money Raised By Biotech In 2003 Vs. 2002.
March 10, 2003... Money Raised By Biotech In 2003 Vs. 2002 Jan. 1 - March 6, Jan. 1 - March 7, 2003: $1,152.14M 2002: $4,293.13M Public/Other * 387 3,209 Private Biotechs 422 ...

10 Biggest U.S. Gainers & Losers for the Week.
March 10, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Interleukin 42.86 Trimeris 3.08 Oxis Int'l 33.33 Gilead Sciences 2.80 Antex Biologics 30.00 ImClone Sys ...

Public Financing Of Biotechnology: February 2003.
March 10, 2003... Public Financing Of Biotechnology: February 2003 I. COMMENCED TRADING IN FEBRUARY Company Date Date Shares/ Price Shares Lead, Other Gross (Symbol) Filed Comm. Units (M) Out Underwriters (M) ...

Other Financings Of Public Biotechnology Companies: February 2003.
March 10, 2003... Other Financings Of Public Biotechnology Companies: February 2003 TOTAL: $153.903M Number of Amount Company Type Of Shares, Units Raised (Symbol) # ...

Venture Capital And Corporate Investments In Biotechnology Companies: February 2003.
March 10, 2003... Venture Capital And Corporate Investments In Biotechnology Companies: February 2003 I. FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $144.64M Company Location Date Amt. (M) Ardais Corp. Lexington,...

Money Raised By Biotech In 2003: January-February.
March 10, 2003... Money Raised By Biotech In 2003: January - February Type of financing I ($M) F $(M) Total ($M) Public offerings 254.2 81.9 336.1 Private biotechs 277.7 144.6 422.3 Public/other 104.3 153.9 ...

BioWorld Stock Report For Public Biotechnology Companies.
March 10, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change Vol 2/28 3/7 WK YTD (000) 3D Pharma DDDP 5.71 5.71...

FDA's 'two-animal' rule becomes part of Vical's anthrax vaccine bid.
March 17, 2003... What better way to turn around a company than on the government's dime? Such is the most cynical view possible of companies lining up in economically troubled (and otherwise troubled) times to grab research dollars from Project Bioshield,...

Money Raised By Biotech In 2003 Vs. 2002.
March 17, 2003... Money Raised By Biotech In 2003 Vs. 2002 Millions Jan. 1 - March 13, Jan. 1 - March 14, 2003: $1,284.57M 2002: $4,547.05M Public/Other * 397 ...

10 Biggest U.S. Gainers & Losers for the Week.
March 17, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) NeoRx Corp. 54.76 Martek Bio 3.66 CytRx 33.33 Genzyme 2.83 Targeted Genetics 33.33 Gilead Sciences ...

Clinical Trial Update: February 2003.
March 17, 2003... Clinical Trial Update: February 2003 Company * Product (Country; Symbol) AUTOIMMUNE La Jolla Riquent Riquent Pharmaceutical Co. (LJPC) CANCER AltaRex Corp. OvaRex...

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations and Approvals: February 2003.
March 17, 2003... Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: February 2003 Company * (Country; Symbol) Product Description AUTOIMMUNE Biogen Inc. Amevive Alefacept; novel...

FDA Submissions, Approvals and Other Actions: February 2003.
March 17, 2003... FDA Submissions, Approvals And Other Actions: February 2003 Company * Product (Country; Symbol) AUTOIMMUNE Biogen Inc. Avonex (BGEN) (FDA-approved) ...

BioWorld Stock Report for Public Biotechnology Companies.
March 17, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change 3/7 3/14 WK YTD 3D Pharma DDDP 5.71 5.72 ...

Investors edgy after Isis failure; Genta's drug next antisense test.
March 24, 2003... Last week's blowup of Isis Pharmaceuticals Inc.'s antisense drug, Affinitak, in a Phase III trial for non-small-cell lung cancer placed a question mark above that category of therapeutics, but nobody is flying the white flag of surrender yet....

10 Biggest U.S. Gainers & Losers for the Week.
March 24, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Geron 106.71 IGEN 5.28 Interleukin 67.02 IDEC Pharma 4.03 Demegen 33.33 Integra LifeSci 3.30...

Money Raised by Biotech in 2003 vs. 2002.
March 24, 2003... Money Raised By Biotech In 2003 Vs. 2002 Jan. 1 -- March 30, Jan. 1 -- March 21, 2003: $1,530.6M 2002: $4,860.55M Public/Other * 406 3,274 Private Biotechs ...

Collaborations Between Biotechnology Companies and Universities/Non-Profit Institutions: Nov. 16, 2002-March 19, 2003.
March 24, 2003... Collaborations Between Biotechnology Companies And Universities/Non-Profit Institutions: Nov. 16, 2002 - March 19, 2003 Company * University/ (Country; Symbol) Non-Profit @ Acambis plc...

BioWorld Stock Report for Public Biotechnology Companies.
March 24, 2003... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close % Change 3/14 3/21 WK YTD 3D Pharma DDDP 5.72 5.73 ...

Informed-consent rules can add glitch to design of cancer trials.
March 31, 2003... Genentech Inc., called the "premier" biotechnology firm by Elise Wang, analyst with Salomon Smith Barney -- and Wang is hardly alone in her opinion -- stands as one of the more closely watched companies in the biotechnology sector (maybe even...

Money raised by biotech in 2003 vs. 2002.
March 31, 2003... Money Raised By Biotech In 2003 Vs. 2002 Jan. 1 - March 27, 2002: Jan. 1 - March 28, 2002: $1,628.76M $5,019.87M Public/Other * 440 3,346...

10 biggest U.S. gainers and losers for the week.
March 31, 2003... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Genaera 96.67 ImClone Sys 2.14 Demegen 50.00 CIMA Labs 2.04 Paradigm Genetics 48.78 Flamel Tech 2.00...

Biotech -- big pharma collaborations: new agreements, Dec. 19, 2002 -- March 24, 2003 #.
March 31, 2003... Biotech -- Big Pharma Collaborations: New Agreements, Dec. 19, 2002 -- March 24, 2003 # Biotech Co. * Pharma Co. (Country; (Country) Symbol) 4SC AG * Boehringer (Germany) ...

Manufacturing, marketing and distribution agreements between Biotech and pharmaceutical companies: Dec. 19, 2002 - March 24, 2003.
March 31, 2003... Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Dec. 19, 2002 - March 24, 2003 # Biotech Co. * Pharma Co. (Country; (Country)...

Biotech -- big pharma collaborations: modified and terminated agreements, Dec. 19, 2002 -- March 24, 2003 #.
March 31, 2003... Biotech -- Big Pharma Collaborations: Modified And Terminated Agreements, Dec. 19, 2002 -- March 24, 2003 # 1. MODIFIED AGREEMENTS Biotech Co. * Pharma Co. (Country: Symbol) (Country) ...

BioWorld stock report for public biotechnology companies.
March 31, 2003... BioWorld Stock Report For Public Biotechnology Companies % Company Symbol Close Close Change 3/21 ...